James Turkson
- Oncology top 0.1%
- Molecular Biology top 0.5%
- Immunology top 0.5%
- Pathology and Forensic Medicine top 0.2%
- Cancer Research top 0.5%
- Co-authors
- Richard JoveTammy BowmanRoy GarciaKhandaker SiddiqueePeibin YueEric B. HauraSaı̈d M. SebtiShumin Zhang
- Topics
- Cytokine Signaling Pathways and Interactions (69 papers)PI3K/AKT/mTOR signaling in cancer (30 papers)Cancer Mechanisms and Therapy (20 papers)
- Cited by
- OncologyToxicologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- United StatesCanadaArgentina
In The Last Decade
James Turkson
106 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 9.5k
- Molecular Biology 7.9k
- Immunology 3.2k
- Pathology and Forensic Medicine 2.9k
- Cancer Research 2.5k
Countries citing papers authored by James Turkson
This map shows the geographic impact of James Turkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Turkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Turkson more than expected).
Fields of papers citing papers by James Turkson
This network shows the impact of papers produced by James Turkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Turkson. The network helps show where James Turkson may publish in the future.
Co-authorship network of co-authors of James Turkson
This figure shows the co-authorship network connecting the top 25 collaborators of James Turkson. A scholar is included among the top collaborators of James Turkson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Turkson. James Turkson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 22 | |
| 3 | 12 | |
| 4 | 20 | |
| 5 | 27 | |
| 6 | 4 | |
| 7 | 60 | |
| 8 | 48 | |
| 9 | 124 | |
| 10 | 28 | |
| 11 | 52 | |
| 12 | 70 | |
| 13 | 87 | |
| 14 | 135 | |
| 15 | Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathwaysbreakdown → | 489 |
| 16 | 89 | |
| 17 | 315 | |
| 18 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisbreakdown → | 1019 |
| 19 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionbreakdown → | 505 |
| 20 | 226 |
About James Turkson
James Turkson is a scholar working on Oncology, Pathology and Forensic Medicine and Biotechnology, having authored 109 papers that have together received 15.5k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (69 papers), PI3K/AKT/mTOR signaling in cancer (30 papers) and Cancer Mechanisms and Therapy (20 papers). The work is most often cited by research in Oncology (9.5k citations), Toxicology (706 citations) and Cancer Research (2.5k citations). James Turkson has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Richard Jove, Tammy Bowman, Roy Garcia, Khandaker Siddiquee, Peibin Yue, Eric B. Haura, Saı̈d M. Sebti, Shumin Zhang, James G. Karras and Robyn Catlett-Falcone. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.